Related Experiment Video
Updated: Aug 2, 2026
09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Association of multiple sclerosis with ILT6 deficiency
S Koch1, R Goedde, V Nigmatova
1Department of Clinical Immunology, Medical School, Hannover, Germany.
Genes and Immunity
|April 9, 2005
Summary
A specific gene deletion, known as InterleukinT-6 (ILT6) deficiency, is more common in individuals with multiple sclerosis (MS). This finding suggests ILT6 deficiency may be a genetic risk factor for developing MS.
Area of Science:
- Genetics
- Immunology
- Neurology
Background:
- Multiple sclerosis (MS) is an autoimmune disease with significant genetic influences.
- The ILT6 gene, located at chromosome region 19q13, is a candidate gene for MS due to its role in immunological tolerance.
- Variability in the ILT6 gene, including deletions, can impair its function.
Purpose of the Study:
- To investigate the association between ILT6 gene deletion and the risk of developing multiple sclerosis.
- To determine if ILT6 deficiency is a significant risk factor for MS in specific populations.
Main Methods:
- Polymerase Chain Reaction (PCR) typing was employed to detect ILT6 deficiency.
- The study analyzed blood samples from healthy blood donors and patients diagnosed with MS.
- Populations included Caucasian Germans and French individuals.
Main Results:
- Homozygous ILT6 deficiencies were found in 7.1% of MS patients compared to 3.8% of blood donors.
- This difference was statistically significant (P=0.009).
- ILT6 deficiency was significantly associated with MS in the German population.
Conclusions:
- ILT6 deficiency is associated with multiple sclerosis in the German population.
- ILT6 deficiency represents a potential genetic risk factor for autoimmune disorders like MS.
- Further research into the role of ILT6 in immune regulation and MS pathogenesis is warranted.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...